Zoetis Inc. (ZTS) on Wednesday announced that Health Canada has approved Lenivia for the alleviation of pain associated with osteoarthritis (OA) in dogs.
Lenivia demonstrated a strong safety profile in a nine-month field study, with dogs showing improved mobility and reduced pain after a single injection.
The company said Lenivia relieves OA pain for three months with a single injection through its novel binding to nerve growth factor (NGF), a key mediator of pain and inflammation.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.